ASX BRIEFS

Send us Fan Mail

Australia’s Iron Corridor is one of the busiest shipping routes on earth—and one of the hardest to decarbonise. We sit down with NH3 Clean Energy chair Charles Whitfield to map a practical path forward: large-scale clean ammonia produced in the Pilbara, bunkered at Dampier, and burned by a new generation of ammonia-ready ships. Instead of chasing hype, we dig into the concrete pieces now falling into place: a 650,000 tpa phase one (scaling to 1.3 million), a 2029 first production target, and a landmark MOU with Mitsui O.S.K. Lines and Oceania Marine Energy to build a reliable bunkering ecosystem.

We unpack the demand flywheel driven by Japanese and Korean energy policies and the looming economics of the IMO’s carbon pricing from 2028. Charles explains why an end-to-end value chain matters—production at Maitland, near-port storage for fast turnarounds, refuelling tankers operated by Oceania, and MOL’s leadership on the Pilbara–Asia route—to make switching easy for iron ore exporters. A scarce 7.5-hectare site at the Port of Dampier emerges as a quiet game-changer, enabling storage buffers, efficient loading, and scalable capacity for both export cargoes and marine fuel, reducing bottlenecks and downtime.

We also talk investor milestones on the road to a 2026 final investment decision: approvals, detailed engineering, construction and operations agreements, and financing pathways. Whether via traditional project finance and an EPC partner or a build–own–operate collaboration, the team’s strategy is to de-risk delivery while aligning with Western Australia’s push to become a global renewable energy powerhouse. If you’re tracking clean shipping, hydrogen and ammonia markets, or ASX-listed energy transition plays, this conversation lays out the how, not just the why.

Enjoyed the chat? Follow the show, share this episode with a colleague in shipping or resources, and leave a short review to help more people find thoughtful conversations on clean energy and decarbonised trade.

Send us Fan Mail

What if the real competitive edge in enterprise transformation isn’t a new tool, but the ability to deliver at speed with trust? We sit down with StepChange Holdings’ managing director Shane Bransby to unpack how a fresh ASX listing became a lever for credibility, talent, and tier-one wins—especially across Western Australia’s resource-heavy economy where multi-year programs demand both governance and grit.

We explore why demand for ERP transformation keeps rising: capital projects in mining and energy, the urgency of cloud migration, and the push for measurable productivity gains in finance, HR, and supply chain. From SAP-led programs to pragmatic client-side integration, we share the playbook that’s helping StepChange beat prospectus forecasts and grow to 161 billable consultants. Being sovereign-based and on the ground in Perth matters here—shorter feedback loops, tighter security postures, and a delivery culture that prioritises outcomes over slideware.

You’ll hear how cloud is the true starting line for AI, not the finish, and why structured ERP data unlocks practical automation—from invoice coding and asset maintenance to demand planning and spend analytics. We also talk through the growth thesis for FY26: steady organic demand from tier-one clients, a measured M&A strategy to add specialisation and scale, and the operating discipline that turns programs into referenceable wins. If you care about SAP, cloud ERP, AI readiness, or the realities of building a credible consultancy on the ASX, this conversation offers a clear, actionable view of what creates value right now.

If this resonated, follow the show, share it with a colleague, and leave a quick review—your support helps more leaders find conversations like this.

Send us Fan Mail

Healthcare shouldn’t feel like a maze. In this candid talk with Global Health Managing Director Mathew Cherian, we unpack how a connected SaaS stack—MasterCare+ for clinicians, Lifecard for consumers, HotHealth as the digital front door, and ReferralNet for secure messaging—can turn fragmented journeys into coordinated care. The stakes are real: chronic mental health, diabetes, cardiovascular disease, and AOD services demand team-based workflows that stretch from hospital to home. With budgets tight across public and private sectors, the only path forward is smarter systems that do more with less.

Mathew explains the company’s heavy lift from legacy desktop to modern SaaS and AI, a three-year investment that’s now driving a 6% subscription revenue lift and a return to positive operating margins. We dig into practical AI: scribes that cut documentation time, triage avatars that route people to the right help, and clinical documentation support that raises quality and compliance. The vision is grounded—open integrations, best-of-breed components, and choice for customers—so organisations can adopt the right tools without lock-in.

We also explore growth levers: Lifecard’s refreshed UI/UX and new monetisation via direct-to-consumer and B2B2C models; a partnership with Best Practice that opens access to 6,000+ GP practices; and a measured international push into ASEAN markets where ageing populations and chronic disease trends mirror Australia’s. With R&D spend tapering and more than a dozen implementations underway, the team is shifting energy to sales, marketing, and repeatable migrations that compress delivery timelines and improve margins. The message to investors is clear: complete the SaaS transition in 12–18 months, grow ARR, and return to profitability by June 2026, with a portfolio that follows the patient from first consult to recovery across settings.

If you value thoughtful takes on digital health, AI in care delivery, and the hard work of turning platforms into outcomes, this conversation is for you. Subscribe, share with a colleague who’s wrestling with care coordination, and leave a review with your biggest question about patient-controlled records.

Send us Fan Mail

Rare earth elements are the unsung heroes powering everything from wind turbines to guided missiles, yet securing their supply remains one of the greatest challenges in the transition to clean energy and advanced technologies. In this revealing conversation with Andrew Reid, Managing Director of Brazilian Critical Minerals, we explore a breakthrough that could fundamentally alter the rare earth landscape.

The results from BCM's in-situ pilot trials at their Ema Project in Brazil have exceeded all expectations. Solution grades reaching nearly 8,000 ppm – far surpassing laboratory predictions – demonstrate the exceptional leaching characteristics of their ionic clay deposit. "Every time we ask it to perform, it's been able to deliver quite outstanding results," Reid explains. Perhaps most striking is how the mineralization, while not exceptionally high-grade in the ground, achieves remarkable recovery rates through their innovative extraction approach.

What truly sets the Ema Project apart is its economic profile. With a projected capital cost of just US$55 million – a fraction of what competitors require – BCM has positioned itself to potentially become the next commercial rare earth producer outside China. This capital efficiency isn't just good for investors; it dramatically accelerates the timeline to production at a moment when rare earth prices have surged 30% in recent months. The project's unique composition includes significant quantities of samarium and other middle rare earths crucial for defense and aerospace applications, making it exceptionally valuable for strategic industries.

As the company progresses toward completion of its feasibility study in early 2024, the Ema Project represents a potential turning point in Western efforts to secure critical mineral supply chains. For investors watching the critical minerals space, Brazilian Critical Minerals offers a compelling combination of technical innovation, capital efficiency, and strategic value that's worth following closely. Subscribe to hear more breakthrough stories from companies transforming the resources landscape.

Send us Fan Mail

A blocked artery isn’t the end of the story—what happens when blood rushes back can decide how much tissue survives. We sit down with Nyrada CEO James Bonner to unpack how Xolatryp, a small molecule TRPC channel blocker, aims to protect mitochondria, cut calcium overload, and reduce injury after heart attack, traumatic brain injury, and stroke. With Phase I safety in the bank and a Phase IIA study planned for PCI patients, we dig into the practical metrics that matter: MRI‑based infarct size, blood biomarkers, heart function, and arrhythmia rates.

James explains why mitochondrial stability is the hinge point in ischemia‑reperfusion injury and how preclinical work with the Walter Reed Army Institute of Research supports Xolatryp’s mechanism. We talk through the study design choices that bring the drug into the cath lab at the right moment, the potential to standardize dosing alongside angioplasty, and the broader clinical logic that could translate across cardiology and neurology. The conversation also explores Nyrada’s IP moat with a composition‑of‑matter patent, the company’s lean, virtual operating model, and a funding plan combining new equity and R&D rebates to carry the program through Phase IIA.

If you care about where the next leap in acute care may come from, this is a grounded look at a therapy built for minutes‑matter medicine. We share Nyrada’s two‑to‑three‑year outlook, including a licensing‑by‑indication strategy across key markets, and frame the market size anchored by roughly two million annual PCI procedures in developed regions. Subscribe for more ASX‑focused biotech briefings, share this with a colleague who tracks cardiovascular or neuro trauma innovations, and leave a review to tell us which endpoints you believe should define success.

Send us Fan Mail

Dive deep into Medallion Metals ambitious gold and copper development strategy with Managing Director Paul Bennett in this revealing conversation. Paul outlines how the company is revolutionising their approach by acquiring the Forrestania processing infrastructure from IGO, a move that dramatically reduces both time and capital requirements on their path to production.

With impressive mineral resources of 1.1 million ounces of gold and 40,000 tonnes of copper in Western Australia's southern goldfields, Medallion is strategically positioned for growth. Paul explains their calculated decision to secure a secondary ball mill ahead of final investment decision, keeping them on track for first metal production by late 2026 and commercial production in 2027.

The economics look compelling – their previous scoping study showed a $329 million NPV and 129% IRR, figures that are likely to improve substantially given rising gold prices and plans to increase mill throughput. Recent drilling at the Kundip Mining Centre has revealed exciting new loads that could extend mine life and increase production rates, while strong interest from offtake partners (with some offering funding solutions up to $85 million) validates the project's quality.

With $29 million in cash reserves and a clear development pathway, Medallion Metals stands at the threshold of transformation. Whether you're an investor seeking exposure to precious metals, a mining enthusiast tracking emerging producers, or simply curious about innovative approaches in the resources sector, this episode offers valuable insights into a company poised for significant growth. Subscribe to ASX Briefs for more conversations with the leaders shaping Australia's mining future.

Send us Fan Mail

The global logistics industry is long overdue for a technological revolution. With most systems still running on software developed 25-30 years ago, freight forwarders and customs brokers have been starved of innovation and choice. That's where Yojee Limited steps in.

Mark Connell, CEO of Yojee Limited, reveals how his company is disrupting traditional logistics models with their groundbreaking MOSAIC platform. Unlike competitors who simply build "better mousetraps," Yojee approaches longstanding industry problems from entirely fresh angles. Their single, seamless global platform unites supply chain participants in a community-driven ecosystem that simplifies cargo management while challenging entrenched incumbents.

The market response has been extraordinary. Following MOSAIC's unveiling at Australia's largest freight forwarding conference, Yojee saw their share price jump as industry insiders rushed to invest. A recent heavily oversubscribed capital raise will accelerate R&D at their Sydney headquarters and support expansion of their Transport Carrier Management System (TCMS) across Asia Pacific.

Perhaps most impressive is Yojee's strategic shortcutting of barriers that have kept others from challenging industry monopolies. Through their SmartYojee joint venture, they've secured critical customs technology—typically taking years to develop—reducing both time-to-market and costs by 2-5 years. Meanwhile, enterprise contracts with major players like APP Indonesia and Röhlig Logistics Singapore are providing immediate revenue streams.

What's next? Their beta program remains on track for completion this quarter, with revenue-generating contracts expected in early 2026. From there, expansion will continue across Australia, New Zealand, Southeast Asia and eventually into Africa and Latin America. Want to witness a logistics revolution in action? Yojee is definitely one to watch.

Send us Fan Mail

Discover how Critica Limited is positioning itself to become Australia's next rare earth developer through its flagship Jupiter project – the largest clay-hosted rare earth deposit in Australia with an impressive 1.8 billion tons of resource at 1,700 ppm TREO.

CEO Jacob Deysel, a mining engineer with nearly three decades of global experience, reveals the three key advantages setting Jupiter apart: scale, simplicity, and speed. The project's innovative beneficiation-first approach reduces mass by 95% while achieving an 800% upgrade in feed grade using conventional metallurgical equipment. This pathway delivers a high-grade mixed rare earth carbonate while keeping capital expenditure, operating costs, and environmental footprint exceptionally lean.

What makes Jupiter particularly valuable is its rich concentration of magnet rare earth elements – neodymium, praseodymium, terbium, and dysprosium – which represent 80-90% of the basket value and are essential for manufacturing permanent magnets that power future technologies. With China controlling approximately 70% of global mining and 90% of refining capacity, Western manufacturers are urgently seeking alternative, transparent, and ESG-compliant supplies of these critical minerals.

Jupiter's concentrate also features exceptionally low uranium and thorium levels, simplifying approvals, shipping logistics, and market access to sensitive regions including the US, Japan, Korea, and Europe. Beyond Jupiter, satellite discoveries at Aurora and Juno demonstrate the district-scale potential of the Brothers project, potentially transforming it from a single-deposit story into a multi-deposit rare earth district.

Listen as Jacob outlines Critica's ambitious development timeline, including partnerships with ANSTO, Minutech, and GAVAQ to advance their metallurgical program, a pilot plant to upscale beneficiation, and a comprehensive scoping study expected before mid-2024. Subscribe to ASX Briefs for ongoing updates as Critica works to transform Jupiter from a world-class resource into Australia's next rare earth development success story.

Send us Fan Mail

Ever wondered how a small Australian explorer becomes a key player in America's critical minerals strategy? Jindalee Lithium's story might just be the blueprint.

The race for battery metal security is reshaping global mining, and Jindalee has positioned itself at the center of America's lithium ambitions. In this compelling conversation with CEO Ian Rodger, we dive deep into the McDermitt Project – one of the largest lithium resources in the United States, strategically located on the Oregon-Nevada border.

What makes this discussion particularly timely is Jindalee's recently announced SPAC transaction that values McDermitt at a staggering US$500 million while allowing the company to retain approximately 80% ownership. This clever structure opens doors to deep US capital markets without surrendering control, creating a dedicated vehicle to advance the project toward production. As Ian explains, "The natural long-term owners of this project are US investors," highlighting the strategic wisdom behind this corporate maneuver.

The McDermitt Project's significance extends beyond its size. Its designation under FAST-41 (one of just ten projects nationwide) and collaborative agreements with the Department of Energy underscore its importance to American mineral security. 

After two challenging years for lithium markets, green shoots are emerging – perfect timing as Jindalee transitions from explorer to developer. For investors seeking exposure to the critical minerals space, this ASX-listed company offers a compelling entry point to America's lithium future. Subscribe now to stay updated on Jindalee's journey and discover more strategic opportunities reshaping global supply chains.

Send us Fan Mail

Water is our most precious resource, yet industries worldwide face increasingly complex challenges in using it efficiently and responsibly. In this fascinating conversation with Seán Halpin, Managing Director & CEO of SciDev Limited (ASX: SDV), we explore how this Australian company is revolutionising water treatment across multiple sectors with proprietary technologies that deliver both environmental and economic benefits.

Seán reveals SciDev's dual-focused business model spanning Chemical Services and Water Technologies, united by a compelling purpose: solving industry's most complex water problems. The company helps heavy industry reduce fresh water consumption, promote efficient water use, minimise contaminated water production, and repair legacy environmental damage across mining, energy, infrastructure, remediation and defence sectors.

Despite FY25 being what Seán describes as a "pivotal year" with strategic wins rather than dramatic financial growth, the future looks exceptionally bright. With FY26 revenue guidance of $120-140 million, improved gross margins of 28%, and significant contract wins in Q4, SciDev is positioned for substantial growth. Particularly exciting is their CatChek product for the oil and gas industry, which saw 46% year-on-year growth and secured a master services agreement in the Permian Basin.

Perhaps most intriguing is SciDev's FluorofIX technology tackling PFAS contamination—the "forever chemicals" creating environmental havoc worldwide. Seán reveals the European remediation market alone could be worth an astonishing 2-3 trillion USD. With contracts already secured across Australia, Europe and with the US Department of Defense, SciDev stands at the forefront of solving one of our era's most pressing environmental challenges.

Listen now to discover how SciDev is transforming industrial water challenges into opportunities and why this Australian innovator deserves a spot on your investment watchlist.